Zynex Inc financial data

Symbol
ZYXI on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
9655 Maroon Circle, Englewood, CO
State of incorporation
NV
Fiscal year end
December 31
Former names
ZYNEX MEDICAL HOLDINGS INC (to 7/8/2008), ZYNEX MEDICAL HOLDINGS INC (to 8/12/2005), FOX RIVER HOLDINGS INC (to 1/20/2004), ARIZONA VENTURES INC (to 8/19/2003), CHINA GLOBAL DEVELOPMENT INC (to 1/15/2003), IBONZAI COM INC (to 6/12/2001), LIFE MEDICAL TECHNOLOGIES INC /UT/ (to 5/25/2000)
Latest financial report
10-K - Q4 2024 - Mar 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 398 % -19.4%
Quick Ratio 78.8 % +3.89%
Debt-to-equity 261 % +88.6%
Return On Assets 2.41 % -65.8%
Operating Margin 3.11 % -46.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.9M shares +0.43%
Common Stock, Shares, Outstanding 31.9M shares -3.2%
Entity Public Float 143M USD -30.1%
Common Stock, Value, Issued 32K USD -3.03%
Weighted Average Number of Shares Outstanding, Basic 31.9M shares -10.2%
Weighted Average Number of Shares Outstanding, Diluted 32.3M shares -10.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 192M USD +4.36%
Selling and Marketing Expense 86.6M USD -0.09%
General and Administrative Expense 60.4M USD +24.4%
Costs and Expenses 186M USD +7.39%
Operating Income (Loss) 5.99M USD -44.4%
Nonoperating Income (Expense) -2.36M USD -231%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.63M USD -71.2%
Income Tax Expense (Benefit) 633K USD -82.1%
Net Income (Loss) Attributable to Parent 2.99M USD -69.2%
Earnings Per Share, Basic 0.09 USD/shares -66.7%
Earnings Per Share, Diluted 0.09 USD/shares -66.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.5M USD
Accounts Receivable, after Allowance for Credit Loss, Current 18M USD -32.8%
Inventory, Net 13.9M USD +6.2%
Assets, Current 75.2M USD -14.4%
Deferred Income Tax Assets, Net 4.8M USD +24.2%
Property, Plant and Equipment, Net 3.08M USD -0.96%
Operating Lease, Right-of-Use Asset 9.82M USD -21.5%
Intangible Assets, Net (Excluding Goodwill) 7.25M USD -11.2%
Goodwill 20.4M USD 0%
Assets 122M USD -10.8%
Employee-related Liabilities, Current 5.46M USD -1.53%
Liabilities, Current 16.9M USD -9%
Operating Lease, Liability, Noncurrent 10.2M USD -28.4%
Liabilities 86.4M USD -4.85%
Retained Earnings (Accumulated Deficit) 29.8M USD +11.2%
Stockholders' Equity Attributable to Parent 35.7M USD -22.6%
Liabilities and Equity 122M USD -10.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.07M USD +6.93%
Net Cash Provided by (Used in) Financing Activities -13.6M USD -167%
Net Cash Provided by (Used in) Investing Activities -153K USD +12.1%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 42.2M shares +0.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD -250%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 39.6M USD -11.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 90K USD +1.12%
Deferred Tax Assets, Gross 8.04M USD +47.5%
Operating Lease, Liability 14.2M USD -20.8%
Depreciation 638K USD +3.74%
Payments to Acquire Property, Plant, and Equipment 153K USD -16.8%
Lessee, Operating Lease, Liability, to be Paid 15.5M USD -22.6%
Property, Plant and Equipment, Gross 6.6M USD +12.6%
Operating Lease, Liability, Current 4.03M USD +8.07%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.43M USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.63M USD +2.68%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -1K USD -113%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.29M USD -37.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.24M USD -4.31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.17M USD -48.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 461K USD +101%
Deferred Tax Assets, Net of Valuation Allowance 8.83M USD +9.83%
Share-based Payment Arrangement, Expense 2.99M USD +30.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%